Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3090.0
(0.16%)
JPY 3090.0
(0.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -32.92 Billion JPY | 29.69% |
| 2022 | -46.82 Billion JPY | 3.29% |
| 2021 | -48.41 Billion JPY | 11.14% |
| 2020 | -54.48 Billion JPY | -2.24% |
| 2019 | -53.29 Billion JPY | -4.43% |
| 2018 | -51.03 Billion JPY | -11.82% |
| 2017 | -45.63 Billion JPY | 1.25% |
| 2016 | -46.21 Billion JPY | -62.64% |
| 2015 | -28.41 Billion JPY | 6.88% |
| 2014 | -30.51 Billion JPY | 5.41% |
| 2013 | -32.26 Billion JPY | -14.26% |
| 2012 | -28.23 Billion JPY | -31.84% |
| 2011 | -21.41 Billion JPY | 4.98% |
| 2010 | -22.53 Billion JPY | 6.61% |
| 2009 | -24.13 Billion JPY | -32.7% |
| 2008 | -18.18 Billion JPY | -16.75% |
| 2007 | -15.57 Billion JPY | -24.86% |
| 2006 | -12.47 Billion JPY | -46.36% |
| 2005 | -8.52 Billion JPY | -275.01% |
| 2004 | -2.27 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -40.69 Billion JPY | -12.33% |
| 2024 Q1 | -36.22 Billion JPY | -10.04% |
| 2023 Q2 | -34.08 Billion JPY | 17.55% |
| 2023 Q3 | -29.22 Billion JPY | 14.24% |
| 2023 Q1 | -41.33 Billion JPY | 12.08% |
| 2023 FY | -32.92 Billion JPY | 29.69% |
| 2023 Q4 | -32.92 Billion JPY | -12.64% |
| 2022 Q2 | -49.3 Billion JPY | 0.19% |
| 2022 Q3 | -46.14 Billion JPY | 6.41% |
| 2022 Q4 | -47.01 Billion JPY | -1.87% |
| 2022 FY | -46.82 Billion JPY | 3.29% |
| 2022 Q1 | -49.39 Billion JPY | -2.03% |
| 2021 Q2 | -51.3 Billion JPY | 2.12% |
| 2021 Q3 | -47.7 Billion JPY | 7.01% |
| 2021 Q4 | -48.41 Billion JPY | -1.49% |
| 2021 FY | -48.41 Billion JPY | 11.14% |
| 2021 Q1 | -52.41 Billion JPY | 3.81% |
| 2020 Q4 | -54.48 Billion JPY | -1.53% |
| 2020 Q3 | -53.66 Billion JPY | 0.3% |
| 2020 FY | -54.48 Billion JPY | -2.24% |
| 2020 Q2 | -53.82 Billion JPY | -4.45% |
| 2020 Q1 | -51.53 Billion JPY | 3.3% |
| 2019 Q3 | -48.69 Billion JPY | 5.19% |
| 2019 FY | -53.29 Billion JPY | -4.43% |
| 2019 Q2 | -51.35 Billion JPY | -6.1% |
| 2019 Q1 | -48.4 Billion JPY | 5.14% |
| 2019 Q4 | -53.29 Billion JPY | -9.45% |
| 2018 FY | -51.03 Billion JPY | -11.82% |
| 2018 Q3 | -46.1 Billion JPY | 2.34% |
| 2018 Q2 | -47.21 Billion JPY | -13.26% |
| 2018 Q1 | -41.68 Billion JPY | 8.75% |
| 2018 Q4 | -51.03 Billion JPY | -10.68% |
| 2017 FY | -45.63 Billion JPY | 1.25% |
| 2017 Q4 | -45.68 Billion JPY | -9.48% |
| 2017 Q3 | -41.72 Billion JPY | 7.25% |
| 2017 Q2 | -44.98 Billion JPY | -1.24% |
| 2017 Q1 | -44.43 Billion JPY | 4.04% |
| 2016 Q2 | -42.94 Billion JPY | -23.98% |
| 2016 Q3 | -44.44 Billion JPY | -3.48% |
| 2016 Q1 | -34.63 Billion JPY | -21.9% |
| 2016 Q4 | -46.3 Billion JPY | -4.2% |
| 2016 FY | -46.21 Billion JPY | -62.64% |
| 2015 Q2 | -26.97 Billion JPY | 19.85% |
| 2015 FY | -28.41 Billion JPY | 6.88% |
| 2015 Q4 | -28.41 Billion JPY | -52.6% |
| 2015 Q3 | -18.62 Billion JPY | 30.97% |
| 2015 Q1 | -33.65 Billion JPY | -10.29% |
| 2014 Q3 | -25.63 Billion JPY | 15.5% |
| 2014 Q2 | -30.33 Billion JPY | -5.4% |
| 2014 FY | -30.51 Billion JPY | 5.41% |
| 2014 Q1 | -28.78 Billion JPY | 10.78% |
| 2014 Q4 | -30.51 Billion JPY | -19.05% |
| 2013 Q2 | -27.86 Billion JPY | 2.15% |
| 2013 Q4 | -32.26 Billion JPY | -21.12% |
| 2013 FY | -32.26 Billion JPY | -14.26% |
| 2013 Q1 | -28.47 Billion JPY | -0.86% |
| 2013 Q3 | -26.63 Billion JPY | 4.41% |
| 2012 FY | -28.23 Billion JPY | -31.84% |
| 2012 Q2 | -23.25 Billion JPY | -11.52% |
| 2012 Q3 | -23.02 Billion JPY | 0.97% |
| 2012 Q4 | -28.23 Billion JPY | -22.62% |
| 2012 Q1 | -20.84 Billion JPY | 2.65% |
| 2011 FY | -21.41 Billion JPY | 4.98% |
| 2011 Q3 | -19.71 Billion JPY | 4.67% |
| 2011 Q2 | -20.68 Billion JPY | 12.29% |
| 2011 Q4 | -21.41 Billion JPY | -8.61% |
| 2011 Q1 | -23.58 Billion JPY | -4.63% |
| 2010 Q2 | -21.51 Billion JPY | 6.52% |
| 2010 Q1 | -23.01 Billion JPY | 4.62% |
| 2010 Q3 | -22.46 Billion JPY | -4.4% |
| 2010 FY | -22.53 Billion JPY | 6.61% |
| 2010 Q4 | -22.53 Billion JPY | -0.33% |
| 2009 Q3 | -21.76 Billion JPY | 7.29% |
| 2009 Q4 | -24.13 Billion JPY | -10.88% |
| 2009 FY | -24.13 Billion JPY | -32.7% |
| 2009 Q2 | -23.47 Billion JPY | 0.0% |
| 2008 Q4 | -18.18 Billion JPY | 0.0% |
| 2008 FY | -18.18 Billion JPY | -16.75% |
| 2007 FY | -15.57 Billion JPY | -24.86% |
| 2006 FY | -12.47 Billion JPY | -46.36% |
| 2005 FY | -8.52 Billion JPY | -275.01% |
| 2004 FY | -2.27 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 2787.429% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 100.751% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 108.445% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 90.498% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -823.679% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 21.907% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 46.447% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 66.384% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -4835.682% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 36.472% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 533.057% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 523.095% |
| Tsumura & Co. | 1.61 Billion JPY | 2138.452% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 25.451% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 4.402% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 119.062% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 223.652% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 213.592% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 566.303% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 4776.278% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 649.416% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -405.155% |
| MedRx Co., Ltd | -1.72 Billion JPY | -1814.012% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -277.688% |
| Solasia Pharma K.K. | -668 Million JPY | -4828.293% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -2138.097% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -353.895% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 158.245% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -1011.906% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 66.554% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -195.797% |